Latest news from Seeking Alpha - Markets feed

Latest news from Seeking Alpha - Markets feed

  1. Union buying ads as strike against Charter heats up

    10.04 / 18:16 seekingalpha.com Seeking Alpha - Markets
    A new union ad campaign is the latest sign that a labor dispute between Charter Communications (CHTR +0.2%) and its workers is getting hotter. Some 1,800 workers went on strike in March as Charter looked to eliminate pension contributions and restructure benefit plans, even while it said it was offering significant raises. The workers are set to lose medical coverage next month. The Local 3 International Brotherhood of Electrical Workers has made a six-figure ad buy that it…
  2. BioCryst Pharma to present new data on Rapivab and antiviral galidesivir at IDWeek

    10.04 / 16:59 seekingalpha.com Seeking Alpha - Markets
    BioCryst Pharmaceuticals (BCRX) announces the presentation of new data on flu vaccine RAPIVAB (peramivir injection) and broad-spectrum antiviral galidesivir (BCX4430) at IDWeek in San Diego. The conference started today and will conclude Sunday. Results from the open-label BCX1812-305 study assessing a single dose of IV RAPIVAB compared to oral oseltamivir (Roche's Tamiflu) for five days in children with acute uncomplicated influenza showed less treatment-emergent adverse events (9% vs.…
  3. Putin signals willingness to extend oil supply deal

    10.04 / 16:59 seekingalpha.com Seeking Alpha - Markets
    Russian Pres. Putin says he is open to extending the oil supply deal with OPEC to the end of 2018, raising the prospect of a longer extension than others have mentioned, although he will wait to make a decision until closer to the March expiration of the existing agreement. OPEC Secretary-General Mohammad Barkindo calls Putin's comments at the Russian Energy Week conference in Moscow a “very strong endorsement” of the deal. Any move also would require the support of Saudi Ara…
  4. Gilead's single-pill combo BIC/FTC/TAF matches multi-tablet bPI regimen in late-stage HIV study

    10.04 / 16:20 seekingalpha.com Seeking Alpha - Markets
    A Phase 3 clinical trial, Study 1878, evaluating Gilead Sciences' (GILD -1.2%) single-tablet, fixed-dose combination of bictegravir (50 mg) and emtricitabine/tenofovir alafenamide (200 mg/25 mg) (BIC/FTC/TAF) for the treatment of adults with HIV-1 infection who switched from a multi-tablet regimen containing a boosted protease inhibitor (bPI) to BIC/FTC/TAF demonstrated non-inferiority after 48 weeks. The data will be presented at IDWeek in San Diego later this week. No …
  5. Heat Bio aims to accelerate development of two pipeline candidates via deal with Selexis; shares ahead 8%

    10.04 / 15:57 seekingalpha.com Seeking Alpha - Markets
    Heat Biologics (HTBX +7.6%) subsidiary Pelican Therapeutics inks an agreement with Selexis SA leveraging its SUREtechnology platform to rapidly develop research cell banks expressing two of Pelican's pipeline candidates: PTX-35 (website says PTX-25), a humanized monoclonal antibody agonist of a tumor necrosis factor (TNF) receptor called TNFRSF25, and PTX-15, a human TL1A-Ig fusion protein. The company says both have the potential to improve clinical response when used with Heat's ImPACT…
  6. Ex-Equifax CEO: Stocks sales look routine; company wins gov't contract

    10.04 / 15:38 seekingalpha.com Seeking Alpha - Markets
    Former Equifax (NYSE:EFX) CEO Richard Smith has been testifying before Congress over the past couple of days, and there's been no major revelations. Of the stock sales by several executives post-breach, but pre-disclosure, they appear to be routine, says Smith. Those who did sell are "honorable men." In one of those "can't make this stuff up" kind of stories, the IRS yesterday awarded a $7.25M contract to Equifax to verify taxpayer identities and help prevent fraud. It's billed as a…
  7. Reuters: EPA to propose repeal of Clean Power Plan

    10.04 / 15:25 seekingalpha.com Seeking Alpha - Markets
    The EPA will propose repealing the Clean Power Plan and plans to solicit input on a rule to replace it, Reuters reports, citing an internal EPA document. The decision marks the EPA’s first formal step to repeal the Obama administration rule intended to cut carbon emissions from power plants, after Pres. Trump signed an executive order in March launching a review. The Clean Power Plan currently is suspended by the D.C. Circuit Court of Appeals, which set a deadline of Friday f…
  8. Crude futures pares losses post inventory data

    10.04 / 14:46 seekingalpha.com Seeking Alpha - Markets
    EIA Petroleum Inventories: Crude -6.0M barrels vs. -0.8M consensus, -1.8M last week. Gasoline +1.6M barrels vs. +1.1M consensus, +1.1M last week. Distillates -2.6M barrels vs. -1.8M consensus, -0.8M last week. Futures -0.38% to $50.23. ETFs:USO, O… …
  9. Amazon approaches French grocer for deal; Alexa coming to Nissan vehicles

    10.04 / 14:46 seekingalpha.com Seeking Alpha - Markets
    Amazon (NASDAQ:AMZN) has approached French supermarket Leclerc as part of its push to partner with or acquire distributors in the region. Leclerc head confirmed the talks to Reuters.  Other reported candidates include Casino and Carrefour.    In other Amazon news, Nissan announces that its vehicles from 2016 to 2018 containing NissanConnect Services will now have a new Alexa skill that can lock or unlock the car, start the car, or turn on the lights o…
  10. Jamba announces acquisition and growth agreement with largest franchise partner, Vitaligent, LLC

    10.04 / 13:11 seekingalpha.com Seeking Alpha - Markets
    Jamba (NASDAQ:JMBA) announced a growth agreement with its largest franchise partner, Vitaligent, LLC, which includes the acquisition of 21 stores from a former franchisee and the development of 12 new stores in the greater Seattle market. This agreement will increase Vitaligent’s operation to 100 stores across California, Missouri, and now, Washington. “Vitaligent shares our vision for continued growth in serving communities where Jamba’s premium, han…
  11. Premarket analyst action - healthcare

    10.04 / 13:11 seekingalpha.com Seeking Alpha - Markets
    Gilead Sciences (NASDAQ:GILD) resumed with Hold rating and $93 (12% upside) price target by Jefferies. Shares are up a fraction premarket. Intercept Pharmaceuticals (NASDAQ:ICPT) downgraded to Market Perform by JMP Securities. Shares down 2% premarket on light volume. Verex Imaging (NASDAQ:VREX) downgraded to Underweight with a $33 (5% downside risk) price target by JPMorgan. Mylan N.V. (NASDAQ:MYL) price target raised to $45 (38% upside) from $42 by BTIG Research after FDA OK of generic …